Marta Alcaraz Fuentes

Dr. Marta Alcaraz Fuentes

Department of ENT, head and neck surgery. Hospital Universitario Sanitas La Zarzuela. Madrid. Spain
+3
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PFPatricia Fernandez-Sanjuan
Patricia Fernandez-Sanjuan
JAJuan José Arrieta
Juan José Arrieta
JSJaime Sanabria
Jaime Sanabria
Marta Alcaraz FuentesMarta Alcaraz Fuentes
Marta Alcaraz Fuentes
GBGabriela Bosco
Gabriela Bosco
GPGuillermo Plaza
Guillermo Plaza
Mandibular advancement devices (MAD) are an effective alternative treatment to CPAP. Different maneuvers were performed during drug sleep-induced endoscopy (DISE) to mimic the effect of MAD. Using the Selector Avance Mandibular (SAM) device, we aimed to identify MAD candidates during DISE using a titratable, reproducible, and measurable maneuver. This DISE-SAM protocol may help to find the relationship between the severity of the respiratory disorder and the degree of response and determine the advancement required to improve the collapsibility of the upper airway. Explorations were performed in 161 patients (132 males; 29 females) with a mean age of 46.81 (SD = 11.42) years, BMI of 27.90 (SD = 4.19) kg/m2, and a mean AHI of 26.51 (SD = 21.23). The results showed no relationship between severity and MAD recommendation. Furthermore, there was a weak positive relationship between the advancement required to obtain a response and the disease severity. Using the DISE-SAM protocol, the response and the range of mandibular protrusion were assessed, avoiding the interexaminer bias of the jaw thrust maneuver. We suggest prescribing MAD as a single, alternative, or multiple treatment approaches following the SAM recommendations in a personalized design.

20 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PFPatricia Fernandez-Sanjuan
Patricia Fernandez-Sanjuan
Marta Alcaraz FuentesMarta Alcaraz Fuentes
Marta Alcaraz Fuentes
GBGabriela Bosco
Gabriela Bosco
NPNuria Perez
Nuria Perez
MGMarta Morato Galan
Marta Morato Galan
GPGuillermo Plaza
Guillermo Plaza
Background: Mandibular advancement devices (MADs) are an effective treatment for patients with sleep-related breathing disorders, with variable response. Increasingly more research points to the predictive value of Drug-Induced Sleep Endoscopy (DISE) in patient selection. This study aims to analyze the changes in upper airway collapsibility using a titratable MAD simulator during DISE. Methods: This study included 104 patients with simple snoring and obstructive sleep apnea (OSA). The VOTE scale was used to assess the presence of collapses during the DISE both without and with the MAD simulator. Results: In snorers, there was a decrease in collapses at the level of the soft palate and oropharynx when the advancement was achieved. Patients with mild OSA also showed a decrease in collapses at the base of the tongue. Patients with moderate/severe OSA exhibited significant amelioration at all levels. The levels at which there were residual collapses despite the maneuver were, in order, the velopharynx, oropharynx, epiglottis, and tongue. Conclusions: The MAD simulator reduces collapsibility at all levels and in all severity groups. Residual collapses suitable for combined treatments were able to be identified. This highlights the need for individualized patient selection, as upper airway collapsibility exhibits variable improvement or worsening with the MAD simulator regardless of the severity of the condition.

2 June 2021 in Current Otorhinolaryngology Reports
Verified
Journal Article
Closed access
PDF file
Marta Alcaraz FuentesMarta Alcaraz Fuentes
Marta Alcaraz Fuentes
GBGabriela Bosco
Gabriela Bosco
NPNuria Perez
Nuria Perez
MMMarta Morato
Marta Morato
ANAndres Navarro
Andres Navarro
GPGuillermo Plaza
Guillermo Plaza

4 August 2026 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
PDF file
PFPatricia Fernández‐Sanjuán
Patricia Fernández‐Sanjuán
GBGabriela Bosco
Gabriela Bosco
NPNuria Perez
Nuria Perez
Marta Alcaraz FuentesMarta Alcaraz Fuentes
Marta Alcaraz Fuentes
JAJuan J. Arrieta
Juan J. Arrieta
GPGuillermo Plaza
Guillermo Plaza
Objective: Mandibular advancement devices (MADs) are a recognized alternative to continuous positive airway pressure (CPAP) for treating obstructive sleep apnea (OSA), though patient selection is still challenging. Tailored MAD guided through drug induced sleep endoscopy (DISE) with a mandibular titratable positioner (SAM) offers a stable and reproducible simulation of MAD effects during DISE, potentially enhancing outcomes after this DISE‐SAM protocol. We aim to assess its positive predictive value (PPV) in patients treated with MAD by analyzing changes in AHI, minimum oxygen saturation, and CT90, considering OSA severity and recommendations based on the expected response. Study Design: Prospective cohort study. Setting: Academic secondary medical centers. Methods: A prospective, multicenter study was conducted including 77 OSA patients across 3 hospitals. After DISE with the SAM device, 66 patients concluded MAD therapy based on SAM recommendations: Single use (S), Alternative (A), or Multiple treatment approach (M). Pretreatment and posttreatment sleep studies measured AHI, Min O 2 Sat, and CT90. Response was analyzed with standard AHI‐oxygen saturation‐based criteria and newly tailored criteria per SAM recommendation category. Results: MAD therapy led to significant improvement in AHI (from 32.26 to 7.19), min O 2 Sat (from 80.83% to 85.87%), and CT90 (from 11.33% to 3.99%). Stratified analyses showed significant treatment effects in moderate and severe OSA groups and across SAM recommendations. The MAD therapy guided through DISE‐SAM protocol demonstrated high PPV, also when using tailored success criteria. Conclusions: The DISE‐SAM protocol demonstrated a high positive predictive value and significant improvements in key respiratory parameters among the selected patients using MAD.